BridgeMD
New treatment option for Unilateral Complete Cleft Lip and Palate
Official title Printed Aligners for Nasoalveolar Molding Treatment
ClinicalTrials.gov ID: NCT06683560
What this study is testing
- What it's testing
- study will provide nasoalveolar molding (NAM) treatment, special care for infants born with cleft lip and palate. This novel appliance will help to provide the care in accurate and easy form by help of both digital work flow and new material which provide a unique properties.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 45
You may be able to join if
- Non-syndromic complete unilateral cleft lip, alveolus, and palate.
- Age is up to 45 days.
- Cleft size more than 5mm between anterior margins of cleft segments.
You likely can't join if
- Infants are diagnosed with other congenital malformations.
- Parents refusing NAM treatment.
- Parents are unable to attend the clinic every 2 weeks.
- Infants are born with another form of clefts like facial and median clefts.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Abbasya, Egypt
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 45 days. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Abbasya, Egypt; Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.